2014-08 to 2018-05 Pharm.D.: University of Nebraska Medical Center
2010-09 to 2014-06 Bachelor's in Pharmacy: Fudan University
Published 28 academic papers, including 23 SCI papers
Co-authored 2 textbooks and English monographs
2018-08 to Present - Fudan University School of Pharmacy - Assistant Researcher
2022: Fudan University 'Zhong Yang-style Teaching Team'
2022: First Prize in the Yangtze River Delta University Clinical Pharmacy Teaching Ability Invitational Competition (Individual)
2021: Second Prize in the Third Course Ideological and Political Teaching Plan Competition of Shanghai Medical College, Fudan University (Individual)
Research
Clinical Drug Therapy Pharmacy Services Pharmaceutical Administration
Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China, Feng Z, Tong WK, Zhang X, Tang Z, 2023
Prevalence of depression and association with all-cause and cardiovascular mortality among individuals with type 2 diabetes: a cohort study based on NHANES 2005–2018 data, Feng Z, Tong WK, Zhang X, Tang Z, 2023
Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization, Gu M, Li A, Mak W, Dong F, Xu N, Zhang J, Shi Y, Zheng N, Tang Z, He Q, Ruan C, Guo W, Xiang X, Wang C, Han B, Zhu X, 2023
Pharmacokinetics of novel furoxan/coumarin hybrids in rats using LC-MS/MS method and physiologically based pharmacokinetic model, Yuan Y, Li Z, Wang K, Zhang S, He Q, Liu L, Tang Z, Zhu X, Chen Y, Cai W, Peng C, Xiang X, 2023
Applications of in silico models to predict drug-induced liver injury, Lin J, Li M, Mak W, Shi Y, Zhu X, Tang Z, He Q, Xiang X, 2022
Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview, Jia Q, He Q, Yao L, Li M, Lin J, Tang Z, Zhu X, Xiang X, 2022
Changes in pharmaceutical retail market and regional inequality of community pharmacists accessibility in mainland China: a retrospective cross-sectional study, Feng Z, Ye Y, Ye H, Tang Z, 2022
Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS, Feng Z, Li X, Tong WK, He Q, Zhu X, Xiang X, Tang Z, 2022
Longitudinal trends in the prevalence and treatment of depression among adults with cardiovascular disease: An analysis of national health and nutrition examination survey 2009–2020, Feng Z, Tong WK, Tang Z, 2022
Case Report: Rhabdomyolysis secondary to vildagliptin overdose in a suicidal attempt: A case report and brief literature review, Tang Z, Fan X, Feng Z, Han B, Guo N, 2022
Frailty in community-dwelling adults aged 40 years and over with type 2 diabetes: association with self-management behaviors, Tang Z, Shen C, Tong WK, Xiang X, Feng Z, Han B, 2022
Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene, Zhang J, Tang Z, Guo X, Wang Y, Zhou Y, Cai W, 2022
Application of physiologically-based pharmacokinetic modeling in preclinical studies: a feasible strategy to practice the principles of 3Rs, Yuan Y, He Q, Zhang S, Li M, Tang Z, Zhu X, Jiao Z, Cai W, Xiang X, 2022
Examination of the impact of CYP3A4/5 on drug–drug interaction between schizandrol A/schizandrol B and tacrolimus (FK-506): a physiologically based pharmacokinetic modeling approach, He Q, Bu F, Wang Q, Li M, Lin J, Tang Z, Mak WY, Zhuang X, Zhu X, Lin H, Xiang X, 2022
我国社会药房执业药师药学服务能力研究, 冯振, 白玛拉姆, 叶桦, 洪兰, 唐至佳, 2021
Investigation of the impact of CYP3A5 polymorphism on drug-drug interaction between tacrolimus and schisantherin A/schisandrin A based on physiologically-based pharmacokinetic modeling, He Q, Bu F, Zhang H, Wang Q, Tang Z, Yuan J, Lin H, Xiang X, 2021
Simultaneous Quantification of Propylthiouracil and Its N-β-d Glucuronide by HPLC-MS/MS: Application to a Metabolic Study, Li M, He Q, Yao L, Wang X, Tang Z, Zhu X, Lin H, Xiang X, 2021
A physiologically based pharmacokinetic/pharmacodynamic modeling approach for drug-drug interaction evaluation of warfarin enantiomers with sorafenib, Wang Z, Xiang X, Liu S, Tang Z, Sun H, Parvez M, Ghim J, Shin J, Cai W, 2021
Validation of the simplified Chinese version of the brief Diabetes Quality of Life (DQoL) questionnaire based on a cross-sectional study, Tang Z, Jiang X, Hong L, Feng Z, He Q, Yuan J, Xiang X, 2020
Current perceptions and improvement approaches of pharmaceutical care capacity of community pharmacists: a quantitative analysis based on survey data at Chinese chain pharmacies, Tang Z, Lhamu P, Ye H, Hong L, Xiang X, 2020
关于部分发达国家（执业）药师继续教育管理现状分析, 唐至佳, 叶桦, 2020
Regulatory oversight of cell therapy in China: Government's efforts in patient access and therapeutic innovation, Wu W, Wang Y, Tang Z, Gao Y, Huo Y, 2020
Effect of tea polyphenols on the oral and intravenous pharmacokinetics of ticagrelor in rats and its in vitro metabolism, Wang Z, Xue Y, Sun H, Zhang Z, Tang Z, Liu S, Cai W, 2020
Pediatric Drug Development in China Reforms and Challenges, Wu W, Tang Z, Chen J, Gao Y, 2019
执业药师资格考试电子化的可行性探讨, 唐至佳, 叶桦, 2019
Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients, Li X, Jin S, Fan Y, Fan X, Tang Z, Cai W, Yang J, Xiang X, 2019
Evaluating tumor metastatic potential by imaging intratumoral acidosis via pH-activatable near-infrared fluorescent probe, Wang L, Fan Z, Zhang J, Changyi Y, Huang C, Gu Y, Xu Z, Tang Z, Lu W, Wei X, Li C, 2015
Keywords
Clinical Drug TherapyPharmacy ServicesPharmaceutical AdministrationDiabetesPharmacokineticsPharmacodynamicsDrug SafetyPharmacovigilancePharmaceutical CareHealth Quality
